No abstract

The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701).

No abstract

This study shows impaired endothelial-dependent forearm vascular relaxation as measured by decreased acetylcholine response in black subjects. This impairment in endothelial function may contribute to the increased incidence of hypertension in black subjects compared with white subjects. Mechanisms for this finding warrant further investigation.

No abstract